Long Term Care Journal
Monday, March 9, 2020
FDA Approves First Treatment for Group of Progressive Interstitial Lung Diseases - FDA Press Releases
The FDA approves treatment for patients with chronic fibrosing (scarring) interstitial lung diseases (ILD) with a progressive phenotype (trait).
from FDA Press Releases RSS Feed https://ift.tt/38C7W1V
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment